NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Work Medical Technology Group Ltd. WOK
4 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$9.8M
▼ 14.4% vs FY2024
EPS · FY25
$-0.04
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-6.8%
Net margin · FY25
-10.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 9.8M
Revenue, FY2025 · full 4-year series below
Revenue
Net income
The company lost 11 cents on every revenue dollar this year.
Per share
USD -0.04
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-6.8%
Return on equity, FY2025
ROE
Operating margin-11.0%
Net margin-10.9%
Return on assets-3.1%
Each USD of equity lost 7 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−20.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 33.2M
total assets, end of FY2025
Total assetsUSD 33.2M
EquityUSD 18.3M
CashUSD 4.1M
Gross debtUSD 6.4M
Net debtUSD 2.3M
Current ratio1.71×
Net debt stands at 13% of equity.
History
4 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
Revenue $B
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
0.0
0.0
Income tax $B
0.0
−0.0
0.0
0.0
Net income $B
−0.0
−0.0
0.0
0.0
EPS, diluted $
−0.04
−0.27
0.01
0.07
Dividend / sh $
·
·
·
·
Payout %
·
·
·
·
ROE %
−6.8
−30.3
1.1
·
Shares out B
·
0.01
0.01
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
10 of 10
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed